Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2024 年第 4 季持倉
持倉截至 2024/12/31，2025/2/14 申報。只含多頭部位，變化是跟 2024 年第 3 季比股數。
- 持股檔數
- 61
- 較 2024 年第 3 季 −20
- 總值
- $10.0 億
- 較 2024 年第 3 季 −$9.57 億 (−48.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. | COM | 2,873,000 | $6,263 萬 | 6.2% | −44,231−1.5% | 減碼 | 歷史 |
| BSXBoston Scientific Corp | Stock | 515,000 | $4,600 萬 | 4.6% | −447,000−46.5% | 減碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 741,900 | $3,972 萬 | 4.0% | +179,900+32.0% | 加碼 | 歷史 |
| NTRANatera, Inc. | COM | 223,800 | $3,543 萬 | 3.5% | −332,600−59.8% | 減碼 | 歷史 |
| EXASExact Sciences Corp | COM | 603,011 | $3,388 萬 | 3.4% | +15,011+2.6% | 加碼 | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 64,800 | $3,382 萬 | 3.4% | −83,400−56.3% | 減碼 | 歷史 |
| CGONCG Oncology, Inc. | COM | 1,097,800 | $3,148 萬 | 3.1% | −558,200−33.7% | 減碼 | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 60,000 | $3,035 萬 | 3.0% | −27,400−31.4% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 220,400 | $3,008 萬 | 3.0% | −239,600−52.1% | 減碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 1,126,700 | $2,896 萬 | 2.9% | −246,300−17.9% | 減碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 234,500 | $2,888 萬 | 2.9% | −196,500−45.6% | 減碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 666,200 | $2,755 萬 | 2.7% | −64,904−8.9% | 減碼 | 歷史 |
| ACHCAcadia Healthcare Company, Inc. | COM | 658,000 | $2,609 萬 | 2.6% | −327,000−33.2% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 1,358,000 | $2,603 萬 | 2.6% | −139,000−9.3% | 減碼 | 歷史 |
| GKOSGLAUKOS Corp | COM | 170,000 | $2,549 萬 | 2.5% | −174,900−50.7% | 減碼 | 歷史 |
| DXCMDexcom Inc | COM | 318,000 | $2,473 萬 | 2.5% | +78,000+32.5% | 加碼 | 歷史 |
| TMOThermo Fisher Scientific Inc. | Stock | 44,600 | $2,320 萬 | 2.3% | −24,000−35.0% | 減碼 | 歷史 |
| HUMHumana Inc | Stock | 89,200 | $2,263 萬 | 2.3% | −40,500−31.2% | 減碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 500,000 | $2,012 萬 | 2.0% | 00.0% | 不變 | 歷史 |
| AVTRAvantor, Inc. | COM | 947,000 | $1,995 萬 | 2.0% | −288,000−23.3% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 1,500,000 | $1,983 萬 | 2.0% | −955,000−38.9% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,165,800 | $1,953 萬 | 1.9% | −966,200−45.3% | 減碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 446,200 | $1,952 萬 | 1.9% | −343,800−43.5% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 474,000 | $1,858 萬 | 1.9% | −344,000−42.1% | 減碼 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 137,000 | $1,729 萬 | 1.7% | −116,000−45.8% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 232,800 | $1,607 萬 | 1.6% | −359,200−60.7% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 188,000 | $1,591 萬 | 1.6% | −108,100−36.5% | 減碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 176,600 | $1,540 萬 | 1.5% | −138,400−43.9% | 減碼 | 歷史 |
| DHRDanaher Corp | Stock | 67,000 | $1,538 萬 | 1.5% | −28,000−29.5% | 減碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 352,000 | $1,481 萬 | 1.5% | −400,000−53.2% | 減碼 | 歷史 |
| ILMNIllumina, Inc. | COM | 109,700 | $1,466 萬 | 1.5% | −182,300−62.4% | 減碼 | 歷史 |
| ABBVAbbVie Inc. | Stock | 80,700 | $1,434 萬 | 1.4% | −19,300−19.3% | 減碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,053,300 | $1,324 萬 | 1.3% | +304,300+40.6% | 加碼 | 歷史 |
| BMYBristol Myers Squibb Co | Stock | 215,000 | $1,216 萬 | 1.2% | −48,000−18.3% | 減碼 | 歷史 |
| TMDXTransMedics Group, Inc. | COM | 192,400 | $1,200 萬 | 1.2% | +164,800+597.1% | 加碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,390,100 | $1,129 萬 | 1.1% | −414,393−23.0% | 減碼 | 歷史 |
| SGRYSurgery Partners, Inc. | Stock | 514,200 | $1,089 萬 | 1.1% | −312,800−37.8% | 減碼 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 1,265,200 | $1,021 萬 | 1.0% | −181,919−12.6% | 減碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 354,000 | $909.8 萬 | 0.9% | −535,700−60.2% | 減碼 | 歷史 |
| INCYIncyte Corp | COM | 129,600 | $895.1 萬 | 0.9% | −178,510−57.9% | 減碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 2,694,600 | $859.6 萬 | 0.9% | −749,402−21.8% | 減碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 62,000 | $853.6 萬 | 0.9% | −57,000−47.9% | 減碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 222,900 | $832.5 萬 | 0.8% | −242,100−52.1% | 減碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 97,000 | $810.1 萬 | 0.8% | −136,000−58.4% | 減碼 | 歷史 |
| IMUXImmunic, Inc. | COM | 7,966,400 | $796.6 萬 | 0.8% | −299,600−3.6% | 減碼 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,477,200 | $785.1 萬 | 0.8% | +60,045+0.8% | 加碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 352,124 | $682.8 萬 | 0.7% | −438,802−55.5% | 減碼 | 歷史 |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 8,400 | $598.4 萬 | 0.6% | +8,400 | 新進 | 歷史 |
| BRKRBruker Corp | COM | 76,300 | $447.3 萬 | 0.4% | +76,300 | 新進 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 100,000 | $422.9 萬 | 0.4% | +100,000 | 新進 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 532,000 | $411.2 萬 | 0.4% | −600,564−53.0% | 減碼 | 歷史 |
| QUREuniQure N.V. | SHS | 222,000 | $392.1 萬 | 0.4% | −451,618−67.0% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 502,600 | $337.7 萬 | 0.3% | 00.0% | 不變依 1 比 10 拆股換算 | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 210,000 | $332.4 萬 | 0.3% | −83,200−28.4% | 減碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 82,000 | $228.1 萬 | 0.2% | +82,000 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 96,000 | $226.2 萬 | 0.2% | −69,000−41.8% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 287,104 | $223.9 萬 | 0.2% | −713,896−71.3% | 減碼 | 歷史 |
| SCYXScynexis Inc | COM NEW | 1,228,910 | $148.7 萬 | 0.1% | −219,818−15.2% | 減碼 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 2,018,500 | $136.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 1,188,178 | $104.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BLUEbluebird bio, Inc. | COM NEW | 81,555 | $68.0 萬 | 0.1% | 00.0% | 不變依 1 比 20 拆股換算 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2024 年第 3 季之後清倉（24 檔）
2024 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 3 季股數 | 2024 年第 3 季市值 | 2024 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| NMRANeumora Therapeutics, Inc. | COM | 1,800,000 | $2,378 萬 | 1.2% | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 320,000 | $2,249 萬 | 1.1% | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 38,200 | $2,071 萬 | 1.1% | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 430,900 | $1,891 萬 | 1.0% | 歷史 |
| NGNENeurogene Inc. | COM | 425,041 | $1,783 萬 | 0.9% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 2,133,872 | $1,780 萬 | 0.9% | 歷史 |
| BNTXBioNTech SE | SPONSORED ADS | 145,000 | $1,722 萬 | 0.9% | 歷史 |
| ZTSZoetis Inc. | Stock | 71,000 | $1,387 萬 | 0.7% | 歷史 |
| IMNMImmunome Inc. | COM | 873,891 | $1,278 萬 | 0.7% | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 154,000 | $904.6 萬 | 0.5% | 歷史 |
| PRVAPrivia Health Group, Inc. | COM | 466,800 | $850.0 萬 | 0.4% | 歷史 |
| HELPHelus Pharma Inc. | COM NEW | 918,000 | $816.1 萬 | 0.4% | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 169,000 | $731.3 萬 | 0.4% | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 425,000 | $711.5 萬 | 0.4% | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $622.6 萬 | 0.3% | 歷史 |
| SNYSanofi | SPONSORED ADR | 100,000 | $576.3 萬 | 0.3% | 歷史 |
| EDITEditas Medicine, Inc. | COM | 1,465,000 | $499.6 萬 | 0.3% | 歷史 |
| IMVTImmunovant, Inc. | COM | 99,000 | $282.2 萬 | 0.1% | 歷史 |
| ANROAlto Neuroscience, Inc. | COM SHS | 240,000 | $274.6 萬 | 0.1% | 歷史 |
| PRMEPrime Medicine, Inc. | COM | 694,000 | $268.6 萬 | 0.1% | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 1,063,000 | $228.5 萬 | 0.1% | 歷史 |
| TILInstil Bio, Inc. | COM NEW | 29,100 | $195.9 萬 | 0.1% | 歷史 |
| PRLDPrelude Therapeutics Inc | COM | 890,000 | $184.2 萬 | 0.1% | 歷史 |
| CMAXCareMax, Inc. | COMM STK | 21,200 | $3.60 萬 | <0.1% | 歷史 |